Sei Investments Co. Cuts Position in Qiagen N.V. $QGEN

Sei Investments Co. decreased its holdings in shares of Qiagen N.V. (NYSE:QGEN) by 9.8% in the first quarter, Holdings Channel.com reports. The firm owned 1,766,782 shares of the company’s stock after selling 192,586 shares during the period. Sei Investments Co.’s holdings in Qiagen were worth $70,742,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Allspring Global Investments Holdings LLC boosted its stake in Qiagen by 10.1% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 3,164,805 shares of the company’s stock worth $143,018,000 after purchasing an additional 290,449 shares in the last quarter. Vanguard Group Inc. grew its position in Qiagen by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 9,542,944 shares of the company’s stock valued at $433,871,000 after purchasing an additional 118,135 shares during the last quarter. Baader Bank Aktiengesellschaft purchased a new stake in Qiagen during the 1st quarter valued at about $1,368,000. Massachusetts Financial Services Co. MA increased its stake in Qiagen by 1.1% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 24,205,881 shares of the company’s stock valued at $1,088,538,000 after purchasing an additional 264,921 shares in the last quarter. Finally, Oak Harvest Investment Services increased its stake in Qiagen by 17.7% during the 4th quarter. Oak Harvest Investment Services now owns 98,722 shares of the company’s stock valued at $4,440,000 after purchasing an additional 14,845 shares in the last quarter. 70.00% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages have recently issued reports on QGEN. TD Cowen reiterated a “hold” rating on shares of Qiagen in a research note on Wednesday, July 15th. Kepler Capital Markets set a $38.60 price target on shares of Qiagen and gave the company a “hold” rating in a report on Thursday, June 25th. Stifel Nicolaus set a $36.00 price target on shares of Qiagen and gave the company a “hold” rating in a research report on Monday, May 18th. Barclays set a $38.00 price objective on shares of Qiagen and gave the stock an “equal weight” rating in a report on Wednesday, April 29th. Finally, Wall Street Zen cut Qiagen from a “buy” rating to a “hold” rating in a research report on Saturday, March 28th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $43.34.

Qiagen Stock Down 0.2%

Shares of Qiagen stock opened at $41.38 on Friday. The company has a market cap of $8.53 billion, a price-to-earnings ratio of 21.61, a price-to-earnings-growth ratio of 4.14 and a beta of 0.64. The company’s 50 day moving average is $38.12 and its 200 day moving average is $42.14. Qiagen N.V. has a twelve month low of $32.53 and a twelve month high of $57.81. The company has a quick ratio of 2.57, a current ratio of 3.21 and a debt-to-equity ratio of 0.49.

Qiagen (NYSE:QGEN) last issued its earnings results on Thursday, May 7th. The company reported $0.54 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.54. Qiagen had a net margin of 19.16% and a return on equity of 14.40%. The company had revenue of $492.32 million for the quarter, compared to analysts’ expectations of $496.15 million. During the same quarter last year, the company posted $0.56 earnings per share. Research analysts anticipate that Qiagen N.V. will post 2.43 EPS for the current year.

Qiagen Increases Dividend

The company also recently declared an annual dividend, which was paid on Tuesday, July 14th. Stockholders of record on Tuesday, July 7th were paid a $0.35 dividend. This is an increase from Qiagen’s previous annual dividend of $0.26. The ex-dividend date was Tuesday, July 7th. This represents a dividend yield of 90.0%. Qiagen’s dividend payout ratio (DPR) is 18.32%.

Qiagen Company Profile

Qiagen NV (NYSE: QGEN) is a global provider of sample and assay technologies designed to enable molecular testing in the fields of molecular diagnostics, applied testing, academic research and pharmaceutical development. The company’s solutions span the full workflow of nucleic acid and protein analysis, offering customers standardized kits, instruments and software tools that streamline the preparation, detection and quantification of DNA, RNA and proteins.

The company’s product portfolio includes nucleic acid extraction and purification systems, polymerase chain reaction (PCR) reagents and instrumentation, digital PCR platforms, next-generation sequencing (NGS) library‐preparation kits and proteomics solutions.